Lakefront Biotherapeutics | GLPG - Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
argenx SE USD 165M 20M 2026-09
AstraZeneca USD 2.78B 260M 2026-09
Biogen USD 921.2M 23.9M 2026-09
Genmab DKK 84M 19M 2026-06
Gilead Sciences USD 1000M 445M 2026-06
GlaxoSmithKline GBP 2.23B 163M 2026-09
GRIFOLS EUR 1.23B 63M 2026-09
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Incyte USD 108.74M 3.79M 2026-09
Merck EUR 2.27B 199M 2026-06
Neurocrine Biosciences USD 61.6M 22.2M 2026-09
Novartis USD 3.57B 137M 2026-09
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 4.19B 1.17B 2026-09
UCB EUR 1.07B 146M 2025-12
Vertex Pharmaceuticals USD 520.7M 31.5M 2026-09